Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAPOVER study in recurrent ovarian cancer
NL-OMON50803Completed
- Sponsor
- Catharina Ziekenhuis
- Start
- Jan 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in ovarian cancer, sponsored by Catharina Ziekenhuis. Started Jan 2023; status: completed.
02
Conditions
ovarian cancer
Beyond the preview
Go deeper on NL-OMON50803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50803.